Matthew Gline
Algemeen Directeur bij ROIVANT SCIENCES LTD.
Vermogen: 193 M $ op 31-01-2025
Profiel
Momenteel bekleedt Matthew Gline de functie van Chief Executive Officer & Director bij Roivant Sciences Ltd. en de functie van Chief Executive Officer voor Roivant Sciences GmbH en Chief Executive Officer voor Roivant Sciences, Inc. (beide zijn dochterondernemingen van Roivant Sciences Ltd.). Hij zit ook in de raad van bestuur van Sumitovant Biopharma, Inc. In zijn vorige loopbaan was de heer Gline Chief Executive Officer & Director bij Montes Archimedes Acquisition Corp. Matthew Gline behaalde een bachelordiploma aan Harvard College.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
ROIVANT SCIENCES LTD.
2,38% | 20-01-2025 | 17 327 546 ( 2,38% ) | 193 M $ | 31-01-2025 |
Laatste nieuws over Matthew Gline
Actieve functies van Matthew Gline
Bedrijven | Functie | Begin |
---|---|---|
ROIVANT SCIENCES LTD. | Algemeen Directeur | 01-01-2021 |
Sumitovant Biopharma, Inc.
![]() Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Directeur/Bestuurslid | - |
Roivant Sciences GmbH
![]() Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Algemeen Directeur | 01-01-2021 |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Algemeen Directeur | 01-01-2021 |
Roivant Social Ventures, Inc. | Directeur/Bestuurslid | 01-03-2016 |
Datavant, Inc.
![]() Datavant, Inc. Packaged SoftwareTechnology Services Datavant, Inc. focuses on employing artificial intelligence to improve the clinical trial process. It engages in the discovery, development, and commercialization of new medicines through machine learning. Datavant allows its customers to bring new therapies to patients faster, improve treatment plans, and reduce the cost of care. The company was founded by S. Travis May in 2017 and is headquartered in San Francisco, CA. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Matthew Gline
Bedrijven | Functie | Einde |
---|---|---|
Goldman Sachs & Co. LLC
![]() Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Corporate Officer/Principal | 01-01-2016 |
Fourthrev Ltd.
![]() Fourthrev Ltd. Packaged SoftwareTechnology Services Fourthrev Ltd. brings together leading universities, technology companies, and employer partners to provide learning experiences that lead to qualifications and jobs in the digital economy. Fourthrev is based in Melbourne, Australia, and has subsidiaries in the UK and the US. Jack Hylands and Omar de Silva have been the CEOs since 2019. The British company has built courses with tech giants such as AWS, Salesforce, and Tableau, delivered through university partnerships. Fourthrev courses are available through 11 higher educational providers worldwide, including the University of Coventry, FutureLearn, RMIT, the University of Canberra, and the University of California, Irvine. The company aims to create economic and social value by providing access to high-growth digital careers through their career accelerator model. These online programs accelerate career progression, offer direct paths to in-demand jobs, and provide opportunities for further learning. The company was founded in 2019 by Jack Hylands, Matthew Gline, and Omar de Silva. | Oprichter | 01-03-2014 |
BARCLAYS PLC | Corporate Officer/Principal | 01-01-2012 |
░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | - |
░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
Opleiding van Matthew Gline
Harvard College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ROIVANT SCIENCES LTD. | Health Technology |
BARCLAYS PLC | Finance |
Bedrijven in privébezit | 9 |
---|---|
Urovant Sciences Ltd.
![]() Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Its pipeline includes Vibegron (RVT-901) and URO-902. The company was founded on January 27, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Sumitovant Biopharma, Inc.
![]() Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Health Technology |
Roivant Sciences GmbH
![]() Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Health Technology |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
Montes Archimedes Acquisition Corp.
![]() Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Montes Archimedes Acquisition Corp operates as a blank check company. It is formed for the business purpose to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded James C. Momtazee and Maria C. Walker on July 6, 2020 and is headquartered in Menlo Park, CA. | Finance |
Roivant Social Ventures, Inc. | |
Fourthrev Ltd.
![]() Fourthrev Ltd. Packaged SoftwareTechnology Services Fourthrev Ltd. brings together leading universities, technology companies, and employer partners to provide learning experiences that lead to qualifications and jobs in the digital economy. Fourthrev is based in Melbourne, Australia, and has subsidiaries in the UK and the US. Jack Hylands and Omar de Silva have been the CEOs since 2019. The British company has built courses with tech giants such as AWS, Salesforce, and Tableau, delivered through university partnerships. Fourthrev courses are available through 11 higher educational providers worldwide, including the University of Coventry, FutureLearn, RMIT, the University of Canberra, and the University of California, Irvine. The company aims to create economic and social value by providing access to high-growth digital careers through their career accelerator model. These online programs accelerate career progression, offer direct paths to in-demand jobs, and provide opportunities for further learning. The company was founded in 2019 by Jack Hylands, Matthew Gline, and Omar de Silva. | Technology Services |
Datavant, Inc.
![]() Datavant, Inc. Packaged SoftwareTechnology Services Datavant, Inc. focuses on employing artificial intelligence to improve the clinical trial process. It engages in the discovery, development, and commercialization of new medicines through machine learning. Datavant allows its customers to bring new therapies to patients faster, improve treatment plans, and reduce the cost of care. The company was founded by S. Travis May in 2017 and is headquartered in San Francisco, CA. | Technology Services |
Goldman Sachs & Co. LLC
![]() Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Finance |